DNLI icon

Denali Therapeutics
DNLI

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$36
66% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Thomas Shrader
33% 1-yr DNLI win rate
2 Mar ‘26 1 month ago
Wolfe Research
Wolfe Research
Rudy Li
24 Feb ‘26 1 month ago